THERANOSTIC METHOD BASED ON THE DETECTION OF HER2-HER2 DIMERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150198602A1
SERIAL NO

14415490

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to an ex vivo method for determining the susceptibility of a patient suffering from cancer to respond to a therapeutic treatment based on the administration of an antibody specific for the HER2 protein, this method comprising the quantification of HER2-HER2 dimers in a tissue sample from said patient using the FRET technique.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT GUSTAVE ROUSSY94805 VILLEJUIF CÉDEX
CISBIO BIOASSAYS30200 CODOLET

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andre, Fabrice Sceaux, FR 10 64
Bazin, Herve Villeneuve Les Avignon, FR 23 183
Garnero, Patrick Gaujac, FR 6 22
Mathis, Gerard Bagnols Sur Ceze, FR 26 351

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation